Novogene(SH:688315) Zheng Quan Zhi Xing·2025-09-01 12:19Core Points - The announcement details the resignation of non-independent director Wang Qifeng and his subsequent election as an employee representative director [1][4] - The company held its second employee representative meeting on September 1, 2025, where Wang Qifeng was elected to the fourth board of directors [1][5] - The board also convened its third meeting on the same day to elect members for the strategic committee and the compensation and assessment committee [2][5] Director Resignation - Wang Qifeng resigned from his position as a non-independent director on September 1, 2025, due to adjustments in the company's governance structure [1][3] - His resignation does not affect the minimum number of board members required by law, and it will not impact the company's normal operations [3][4] Employee Director Election - Following Wang Qifeng's resignation, he was elected as an employee director during the employee representative meeting, with his term aligning with the fourth board's term [1][5] - The election ensures that the number of employee representatives on the board does not exceed half of the total board members, complying with relevant regulations [5] Board Committee Adjustments - The third meeting of the fourth board resulted in the election of members for the strategic committee and the compensation and assessment committee [2][5] - The strategic committee is composed of Li Ruiqiang, Wang Qifeng, and Gan Quan, while the compensation and assessment committee includes Wang Chunfei, Wang Tianfan, and Wang Qifeng [5]